{
  "DOI": "10.1007/s00439-005-1300-5",
  "ISSN": [
    "0340-6717",
    "1432-1203"
  ],
  "URL": "http://dx.doi.org/10.1007/s00439-005-1300-5",
  "alternative-id": [
    "1300"
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Matsuzawa",
      "given": "Fumiko",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Aikawa",
      "given": "Sei-ichi",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Doi",
      "given": "Hirofumi",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Okumiya",
      "given": "Toshika",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Sakuraba",
      "given": "Hitoshi",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Human Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": []
  },
  "created": {
    "date-parts": [
      [
        2005,
        5,
        27
      ]
    ],
    "date-time": "2005-05-27T11:53:30Z",
    "timestamp": 1117194810000
  },
  "deposited": {
    "date-parts": [
      [
        2019,
        5,
        28
      ]
    ],
    "date-time": "2019-05-28T23:25:46Z",
    "timestamp": 1559085946000
  },
  "indexed": {
    "date-parts": [
      [
        2024,
        4,
        24
      ]
    ],
    "date-time": "2024-04-24T11:32:46Z",
    "timestamp": 1713958366560
  },
  "is-referenced-by-count": 45,
  "issn-type": [
    {
      "type": "print",
      "value": "0340-6717"
    },
    {
      "type": "electronic",
      "value": "1432-1203"
    }
  ],
  "issue": "4",
  "issued": {
    "date-parts": [
      [
        2005,
        5,
        28
      ]
    ]
  },
  "journal-issue": {
    "issue": "4",
    "published-print": {
      "date-parts": [
        [
          2005,
          8
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2005,
            5,
            28
          ]
        ],
        "date-time": "2005-05-28T00:00:00Z",
        "timestamp": 1117238400000
      }
    }
  ],
  "link": [
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s00439-005-1300-5.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/article/10.1007/s00439-005-1300-5/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s00439-005-1300-5",
      "content-type": "unspecified",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "317-328",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2005,
        5,
        28
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2005,
        5,
        28
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2005,
        8
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1034/j.1399-0004.2001.600107.x",
      "author": "GM Altarescu",
      "doi-asserted-by": "crossref",
      "first-page": "46",
      "journal-title": "Clin Genet",
      "key": "1300_CR1",
      "unstructured": "Altarescu GM, Goldfarb LG, Park KY, Kaneski C, Jeffries N, Litvak S, Nagle JW, Schiffmann R (2001) Identification of 15 novel mutations and genotype-phenotype relationship in Fabry disease. Clin Genet 60:46–51",
      "volume": "60",
      "year": "2001"
    },
    {
      "author": "RJ Desnick",
      "first-page": "3733",
      "key": "1300_CR2",
      "unstructured": "Desnick RJ, Ioannou YA, Eng CM (2001) α-Galactosidase A deficiency: Fabry disease. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease, 8th edn. McGraw-Hill, New York, pp 3733–3774",
      "volume-title": "The metabolic and molecular bases of inherited disease, 8th edn.",
      "year": "2001"
    },
    {
      "DOI": "10.1007/BF01606034",
      "author": "M Elleder",
      "doi-asserted-by": "crossref",
      "first-page": "449",
      "journal-title": "Virchows Arch A Pathol Anat Histopathol",
      "key": "1300_CR3",
      "unstructured": "Elleder M, Bradova V, Smid F, Budesinsky M, Harzer K, Kustermann-Kuhn B, Ledvinova J, Belohlavek, Kral V, Dorazilova V (1990) Cardiocyte storage and hypertrophy as a sole manifestation of Fabry’s disease. Report on a case simulating hypertrophic non-obstructive cardiomyopathy. Virchows Arch A Pathol Anat Histopathol 417:449–455",
      "volume": "417",
      "year": "1990"
    },
    {
      "DOI": "10.1056/NEJM200107053450102",
      "author": "CM Eng",
      "doi-asserted-by": "crossref",
      "first-page": "9",
      "journal-title": "N Engl J Med",
      "key": "1300_CR4",
      "unstructured": "Eng CM, Guffon N, Wilcox WR, Germain DP, Lee P, Waldek S, Caplan L, Linthorst GE, Desnick RJ (2001) Safety and efficacy of recombinant human α-galactosidase A replacement therapy in Fabry’s disease. N Engl J Med 345:9–16",
      "volume": "345",
      "year": "2001"
    },
    {
      "DOI": "10.1056/NEJM200107053450104",
      "author": "A Frustaci",
      "doi-asserted-by": "crossref",
      "first-page": "25",
      "journal-title": "N Engl J Med",
      "key": "1300_CR5",
      "unstructured": "Frustaci A, Chimenti C, Ricci R, Natale L, Russo MA, Pieroni M, Eng CM, Desnick RJ (2001) Improvement in cardiac function in the cardiac variant of Fabry’s disease with galactose-infusion therapy. N Engl J Med 345:25–32",
      "volume": "345",
      "year": "2001"
    },
    {
      "DOI": "10.1016/0272-6386(95)90061-6",
      "author": "M Fukushima",
      "doi-asserted-by": "crossref",
      "first-page": "952",
      "journal-title": "Am J Kidney Dis",
      "key": "1300_CR6",
      "unstructured": "Fukushima M, Tsuchiyama Y, Nakato T, Yokoi T, Ikeda H, Yoshida S, Kusumoto T, Itoh K, Sakuraba H (1995) A female heterozygous patient with Fabry’s disease with renal accumulation of trihexosylceramide detected with a monoclonal antibody. Am J Kidney Dis 26:952–955",
      "volume": "26",
      "year": "1995"
    },
    {
      "DOI": "10.1016/j.jmb.2004.01.035",
      "author": "SC Garman",
      "doi-asserted-by": "crossref",
      "first-page": "319",
      "journal-title": "J Mol Biol",
      "key": "1300_CR7",
      "unstructured": "Garman SC, Garboczi DN (2004) The molecular defect leading to Fabry disease: structure of human α-galactosidase. J Mol Biol 337:319–335",
      "volume": "337",
      "year": "2004"
    },
    {
      "DOI": "10.1006/bbrc.1999.0310",
      "author": "DP Germain",
      "doi-asserted-by": "crossref",
      "first-page": "708",
      "journal-title": "Biochem Biophys Res Commun",
      "key": "1300_CR8",
      "unstructured": "Germain DP, Poenaru L (1999) Fabry disease: identification of novel α-galactosidase A mutations and molecular carrier detection by use of fluorescent chemical cleavage mismatches. Biochem Biophys Res Commun 257:708–713",
      "volume": "257",
      "year": "1999"
    },
    {
      "DOI": "10.1007/BF00207037",
      "author": "S Ishii",
      "doi-asserted-by": "crossref",
      "first-page": "29",
      "journal-title": "Hum Genet",
      "key": "1300_CR9",
      "unstructured": "Ishii S, Sakuraba H, Suzuki Y (1992) Point mutations in the upstream region of the α-galactosidase A exon 6 in an atypical variant of Fabry disease. Hum Genet 89:29–32",
      "volume": "89",
      "year": "1992"
    },
    {
      "DOI": "10.1006/bbrc.1993.2659",
      "author": "S Ishii",
      "doi-asserted-by": "crossref",
      "first-page": "1585",
      "journal-title": "Biochem Biophys Res Commun",
      "key": "1300_CR10",
      "unstructured": "Ishii S, Kase R, Sakuraba H, Suzuki Y (1993) Characterization of a mutant α-galactosidase gene product for the late-onset cardiac form of Fabry disease. Biochem Biophys Res Commun 197:1585–1589",
      "volume": "197",
      "year": "1993"
    },
    {
      "DOI": "10.1111/j.1399-0004.1993.tb03905.x",
      "author": "K Itoh",
      "doi-asserted-by": "crossref",
      "first-page": "302",
      "journal-title": "Clin Genet",
      "key": "1300_CR11",
      "unstructured": "Itoh K, Kotani M, Tai T, Suzuki H, Utsunomiya T, Inoue H, Yamada H, Sakuraba H, Suzuki Y (1993) Immunofluorescence imaging diagnosis of Fabry heterozygotes using confocal laser scanning microscopy. Clin Genet 44:302–306",
      "volume": "44",
      "year": "1993"
    },
    {
      "DOI": "10.1016/S0002-9149(96)00241-X",
      "author": "K Itoh",
      "doi-asserted-by": "crossref",
      "first-page": "116",
      "journal-title": "Am J Cardiol",
      "key": "1300_CR12",
      "unstructured": "Itoh K, Takenaka T, Nakao S, Setoguchi M, Tanaka H, Suzuki T, Sakuraba H (1996) Immunofluorescence analysis of trihexosylceramide accumulated in the hearts of variant hemizygotes and heterozygotes with Fabry disease. Am J Cardiol 78:116–117",
      "volume": "78",
      "year": "1996"
    },
    {
      "author": "W Kabsh",
      "first-page": "827",
      "journal-title": "Acta Crystallogr A",
      "key": "1300_CR13",
      "unstructured": "Kabsh W (1976) A solution for the best rotation to relate two sets of vectors. Acta Crystallogr A 32:827–828",
      "volume": "32",
      "year": "1976"
    },
    {
      "DOI": "10.1107/S0567739478001898",
      "author": "W Kabsh",
      "doi-asserted-by": "crossref",
      "first-page": "922",
      "journal-title": "Acta Crystallogr A",
      "key": "1300_CR14",
      "unstructured": "Kabsh W (1978) A discussion of the solution for the best rotation to relate two sets of vectors. Acta Crystallogr A 34:922–923",
      "volume": "34",
      "year": "1978"
    },
    {
      "DOI": "10.1016/S0925-4439(00)00024-7",
      "author": "R Kase",
      "doi-asserted-by": "crossref",
      "first-page": "227",
      "journal-title": "Biochim Biophys Acta",
      "key": "1300_CR15",
      "unstructured": "Kase R, Bierfreund U, Klein A, Kolter T, Utsumi K, Itoh K, Sandhoff K, Sakuraba H (2000) Characterization of two α-galactosidase mutants (Q279E and R301Q) found in an atypical variant of Fabry disease. Biochim Biophys Acta 1501:227–235",
      "volume": "1501",
      "year": "2000"
    },
    {
      "key": "1300_CR16",
      "unstructured": "Kobori M (2000) Three-dimensional structure of human α-galactosidase, and structural and biological studies on Fabry disease (in Japanese). Doctoral thesis, Faculty of Pharmaceutical Sciences, Graduate School of the University of Tokyo"
    },
    {
      "DOI": "10.1007/BF00219337",
      "author": "P Leinekugel",
      "doi-asserted-by": "crossref",
      "first-page": "513",
      "journal-title": "Hum Genet",
      "key": "1300_CR17",
      "unstructured": "Leinekugel P, Michel S, Conzelmann E, Sandhoff K (1992) Quantitative correlation between the residual activity of β-hexosaminidase A and arylsulfatase A and severity of the resulting lysosomal storage disease. Hum Genet 88:513–523",
      "volume": "88",
      "year": "1992"
    },
    {
      "DOI": "10.1007/s10038-003-0082-7",
      "author": "F Matsuzawa",
      "doi-asserted-by": "crossref",
      "first-page": "582",
      "journal-title": "J Hum Genet",
      "key": "1300_CR18",
      "unstructured": "Matsuzawa F, Aikawa S, Sakuraba H, Lan HT, Tanaka A, Ohno K, Sugimoto Y, Ninomiya H, Doi H (2003) Structural basis of the GM2 gangliosidosis B variant. J Hum Genet 48:582–589",
      "volume": "48",
      "year": "2003"
    },
    {
      "DOI": "10.1111/j.1365-2362.2004.01309.x",
      "author": "A Mehta",
      "doi-asserted-by": "crossref",
      "first-page": "236",
      "journal-title": "Eur J Clin Invest",
      "key": "1300_CR19",
      "unstructured": "Mehta A, Ricci R, Widmer U, Dehout F, Garcia de Lorenzo A, Kampmann C, Linhart A, Sunder-Plassmann G, Ries M, Beck M (2004) Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey. Eur J Clin Invest 34:236–242",
      "volume": "34",
      "year": "2004"
    },
    {
      "DOI": "10.1056/NEJM199508033330504",
      "author": "S Nakao",
      "doi-asserted-by": "crossref",
      "first-page": "288",
      "journal-title": "N Engl J Med",
      "key": "1300_CR20",
      "unstructured": "Nakao S, Takenaka T, Maeda M, Kodama C, Tanaka A, Tahara M, Yoshida A, Kuriyama M, Hayashibe H, Sakuraba H, Tanaka H (1995) An atypical variant of Fabry’s disease in men with left ventricular hypertrophy. N Engl J Med 333:288–293",
      "volume": "333",
      "year": "1995"
    },
    {
      "DOI": "10.1007/BF00223869",
      "author": "T Okumiya",
      "doi-asserted-by": "crossref",
      "first-page": "557",
      "journal-title": "Hum Genet",
      "key": "1300_CR21",
      "unstructured": "Okumiya T, Ishii S, Kase R, Kamei S, Sakuraba H, Suzuki Y (1995a) α-Galactosidase gene mutations in Fabry disease: heterogeneous expressions of mutant enzyme proteins. Hum Genet 95:557–561",
      "volume": "95",
      "year": "1995"
    },
    {
      "DOI": "10.1006/bbrc.1995.2416",
      "author": "T Okumiya",
      "doi-asserted-by": "crossref",
      "first-page": "1219",
      "journal-title": "Biochem Biophys Res Commun",
      "key": "1300_CR22",
      "unstructured": "Okumiya T, Ishii S, Takenaka T, Kase R, Kamei S, Sakuraba H, Suzuki Y (1995b) Galactose stabilizes various missense mutants of α-galactosidase in Fabry disease. Biochem Biophys Res Commun 214:1219–1224",
      "volume": "214",
      "year": "1995"
    },
    {
      "author": "Okumiya",
      "first-page": "S213",
      "journal-title": "Hum",
      "key": "1300_CR23",
      "unstructured": "Okumiya T, Kawamura O, Itoh K, Kase R, Ishii S, Kamei S, Sakuraba H (1998) Novel missense mutation (M72V) of α-galactosidase gene and its expression product in an atypical Fabry hemizygote. Hum Mut (Suppl 1):S213–S216",
      "volume": "Mut",
      "year": "1998"
    },
    {
      "DOI": "10.1111/j.1399-0004.1986.tb01255.x",
      "author": "H Sakuraba",
      "doi-asserted-by": "crossref",
      "first-page": "276",
      "journal-title": "Clin Genet",
      "key": "1300_CR24",
      "unstructured": "Sakuraba H, Yanagawa Y, Igarashi T, Suzuki Y, Suzuki T, Watanabe K, Ieki K, Shimoda K, Yamanaka T (1986) Cardiovascular manifestations in Fabry’s disease. A high incidence of mitral valve prolapse in hemizygotes and heterozygotes. Clin Genet 29:276–283",
      "volume": "29",
      "year": "1986"
    },
    {
      "author": "H Sakuraba",
      "first-page": "784",
      "journal-title": "Am J Hum Genet",
      "key": "1300_CR25",
      "unstructured": "Sakuraba H, Oshima A, Fukuhara Y, Shimmoto M, Nagao Y, Bishop DF, Desnick RJ, Suzuki Y (1990) Identification of point mutations in the α-galactosidase A gene in classical and atypical hemizygotes with Fabry disease. Am J Hum Genet 47:784–789",
      "volume": "47",
      "year": "1990"
    },
    {
      "DOI": "10.1007/s100380200020",
      "author": "H Sakuraba",
      "doi-asserted-by": "crossref",
      "first-page": "176",
      "journal-title": "J Hum Genet",
      "key": "1300_CR26",
      "unstructured": "Sakuraba H, Matsuzawa F, Aikawa S, Doi H, Kotani M, Lin H, Ohno K, Tanaka A, Yamada H, Uyama E (2000) Molecular and structural studies of the GM2 gangliosidosis 0 variant. J Hum Genet 47:176–183",
      "volume": "47",
      "year": "2000"
    },
    {
      "DOI": "10.1007/s10038-003-0098-z",
      "author": "H Sakuraba",
      "doi-asserted-by": "crossref",
      "first-page": "1",
      "journal-title": "J Hum Genet",
      "key": "1300_CR27",
      "unstructured": "Sakuraba H, Matsuzawa F, Aikawa S, Doi H, Kotani M, Nakada H, Fukushige T, Kanzaki T (2004) Structural and immunocytochemical studies on α-N-acetylgalactosaminidase deficiency (Schindler/Kanzaki disease). J Hum Genet 49:1–8",
      "volume": "49",
      "year": "2004"
    },
    {
      "author": "K Sawada",
      "first-page": "289",
      "journal-title": "Clin Nephrol",
      "key": "1300_CR28",
      "unstructured": "Sawada K, Mizoguchi K, Hishida A, Kaneko E, Koide Y, Nishimura K, Kimura M (1996) Point mutation in the α-galactosidase A gene of atypical Fabry disease with only nephropathy. Clin Nephrol 45:289–294",
      "volume": "45",
      "year": "1996"
    },
    {
      "DOI": "10.1056/NEJM199102073240607",
      "author": "W Scheidt von",
      "doi-asserted-by": "crossref",
      "first-page": "395",
      "journal-title": "N Engl J Med",
      "key": "1300_CR29",
      "unstructured": "von Scheidt W, Eng CM, Fitzmaurice TF, Erdmann E, Hubner G, Olsen EG, Christomanou H, Kandolf R, Bishop DF, Desnick RJ (1991) An atypical variant of Fabry’s disease with manifestations confined to the myocardium. N Engl J Med 324:395–399",
      "volume": "324",
      "year": "1991"
    },
    {
      "DOI": "10.1073/pnas.97.1.365",
      "author": "R Schiffmann",
      "doi-asserted-by": "crossref",
      "first-page": "365",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "1300_CR30",
      "unstructured": "Schiffmann R, Murray GJ, Treco D, Daniel P, Sellos-Moura M, Myers M, Quirk JM, Zirzow GC, Borowski M, Loveday K, Anderson T, Gillespie F, Oliver KL, Jeffries NO, Doo E, Liang TJ, Kreps C, Gunter K, Frei K, Crutchfield K, Selden RF, Brady RO (2000) Infusion of α-galactosidase A reduces tissue globotriaosylceramide storage in patients with Fabry disease. Proc Natl Acad Sci USA 97:365–370",
      "volume": "97",
      "year": "2000"
    },
    {
      "DOI": "10.1046/j.1523-1755.2002.00675.x",
      "author": "BL Thurberg",
      "doi-asserted-by": "crossref",
      "first-page": "1933",
      "journal-title": "Kidney Int",
      "key": "1300_CR31",
      "unstructured": "Thurberg BL, Rennke H, Colvin RB, Dikman S, Gordon RE, Collins AB, Desnick RJ, O‘Callaghan M (2002) Globotriaosylceramide accumulation in the Fabry kidney is cleared from multiple cell types after enzyme replacement therapy. Kidney Int 62:1933–1946",
      "volume": "62",
      "year": "2002"
    },
    {
      "DOI": "10.2169/internalmedicine.36.327",
      "author": "K Utsumi",
      "doi-asserted-by": "crossref",
      "first-page": "3227",
      "journal-title": "Int Med",
      "key": "1300_CR32",
      "unstructured": "Utsumi K, Yamamoto N, Kase R, Takata T, Okumiya T, Saito H, Suzuki T, Uyama E, Sakuraba H (1997) High incidence of thrombosis in Fabry’s disease. Int Med 36:3227–3229",
      "volume": "36",
      "year": "1997"
    },
    {
      "DOI": "10.1111/j.1442-200X.1988.tb02495.x",
      "author": "Y Yanagawa",
      "doi-asserted-by": "crossref",
      "first-page": "38",
      "journal-title": "Acta Paediatr Jpn",
      "key": "1300_CR33",
      "unstructured": "Yanagawa Y, Sakuraba H (1988) Cardiovascular manifestations in Fabry’s disease—age-related changes in hemizygotes and heterozygotes. Acta Paediatr Jpn 30:38–48",
      "volume": "30",
      "year": "1988"
    }
  ],
  "reference-count": 33,
  "references-count": 33,
  "resource": {
    "primary": {
      "URL": "http://link.springer.com/10.1007/s00439-005-1300-5"
    }
  },
  "score": 0,
  "short-container-title": [
    "Hum Genet"
  ],
  "source": "Crossref",
  "title": [
    "Fabry disease: correlation between structural changes in α-galactosidase, and clinical and biochemical phenotypes"
  ],
  "type": "journal-article",
  "volume": "117"
}